In summary, addition of 300 μM CNP to low doses of HA (i.e. 0.1 and 0.25 μM, respectively) increased the effect of the GAPDH inhibitor on melanoma cell viability, whereas the viability of melanocytes was unaffected by additional CNP administration. This evidence concerns the gene CNP and melanoma.